1. Home
  2. CME vs SPRC Comparison

CME vs SPRC Comparison

Compare CME & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CME
  • SPRC
  • Stock Information
  • Founded
  • CME 1898
  • SPRC 2004
  • Country
  • CME United States
  • SPRC Israel
  • Employees
  • CME N/A
  • SPRC N/A
  • Industry
  • CME Investment Bankers/Brokers/Service
  • SPRC Biotechnology: Pharmaceutical Preparations
  • Sector
  • CME Finance
  • SPRC Health Care
  • Exchange
  • CME Nasdaq
  • SPRC Nasdaq
  • Market Cap
  • CME N/A
  • SPRC 2.5M
  • IPO Year
  • CME 2002
  • SPRC N/A
  • Fundamental
  • Price
  • CME $238.53
  • SPRC $0.21
  • Analyst Decision
  • CME Hold
  • SPRC
  • Analyst Count
  • CME 16
  • SPRC 0
  • Target Price
  • CME $229.69
  • SPRC N/A
  • AVG Volume (30 Days)
  • CME 2.6M
  • SPRC 600.1K
  • Earning Date
  • CME 02-12-2025
  • SPRC 02-15-2025
  • Dividend Yield
  • CME 4.36%
  • SPRC N/A
  • EPS Growth
  • CME 13.48
  • SPRC N/A
  • EPS
  • CME 9.51
  • SPRC N/A
  • Revenue
  • CME $6,034,400,000.00
  • SPRC $1,747,000.00
  • Revenue This Year
  • CME $11.04
  • SPRC N/A
  • Revenue Next Year
  • CME $2.60
  • SPRC N/A
  • P/E Ratio
  • CME $25.08
  • SPRC N/A
  • Revenue Growth
  • CME 13.05
  • SPRC N/A
  • 52 Week Low
  • CME $190.70
  • SPRC $0.20
  • 52 Week High
  • CME $249.02
  • SPRC $6.78
  • Technical
  • Relative Strength Index (RSI)
  • CME 57.47
  • SPRC 43.06
  • Support Level
  • CME $234.06
  • SPRC $0.20
  • Resistance Level
  • CME $238.60
  • SPRC $0.24
  • Average True Range (ATR)
  • CME 4.54
  • SPRC 0.02
  • MACD
  • CME -0.51
  • SPRC -0.00
  • Stochastic Oscillator
  • CME 29.88
  • SPRC 14.64

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: